Diagnosis and treatment of arteriovenous malformations topical collection on stroke

Current Neurology and Neuroscience Reports

Volumn 13, Issue 2, 2013, Pages

  Mohr, J P ^a   Kejda Scharler, J ^a   Pile Spellman, J ^b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Arteriovenous malformation; ARUBA; bAVM; Diagnosis; Headache; Hemorrhage; Seizures; Treatment

Indexed keywords

ARTERIAL CIRCULATION; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY; BRAIN HEMORRHAGE; BRAIN SURGERY; BRAIN VEIN; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DISEASE SURVEILLANCE; HEADACHE; HUMAN; INVASIVE PROCEDURE; NEUROIMAGING; NEUROLOGIST; PREGNANCY OUTCOME; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEIZURE; TREATMENT PLANNING; VASOCONSTRICTION; BRAIN; RADIOGRAPHY; REVIEW;

BRAIN; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS;

MLCS; MLOWN;

EID: 84873099869     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-012-0324-1     Document Type: Article

References (67)

1. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124:1900-26. (Pubitemid 32951757)
2. Brown Jr RD, Wiebers DO, Torner JC, O'Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996;46:949-52. (Pubitemid 26134632)
3. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Scottish Intracranial Vascular Malformation Study (SIVMS): evaluation of methods, ICD-10 coding, and potential sources of bias in a prospective, population-based cohort. Stroke. 2003;34:1156-62. (Pubitemid 36547506)
4. Mohr JP, Wolf PA, Grotta J, et al. Stroke: pathophysiology, diagnosis, and management, 3 ed, Elsevier Saunders. 2011.
5. Yue NC, Longstreth Jr WT, Elster AD, et al. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. 1997;202:41-6. (Pubitemid 27024106)
6. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA. 1999;282:36-9. (Pubitemid 29318930)
7. Berman MF, Sciacca RR, Pile-Spellman J, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000; 47:389-96; discussion 97.
8. Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207-10. (Pubitemid 20234748)
9. Leblanc GG, Golanov E, Awad IA, Young WL. Biology of vascular malformations of the brain. Stroke. 2009;40:e694-702.
10. Marks MP, Lane B, Steinberg GK, Chang PJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology. 1990;176:807-13. (Pubitemid 20266776)
11. • Stefani MA, Porter PJ, terBrugge KG, et al. Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke. 2002;33:920-4. Detailed description of the may variations in arterial feeders and venous drainage. (Pubitemid 34293568)
12. •• Duong DH, Young WL, Vang MC, et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke. 1998;29:1167-76. Evidence that feeding artery pressure accounts for the major risk of rupture. (Pubitemid 28265473)
13. Josephson CB, Bhattacharya JJ, Counsell CE, et al. Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology. 2012;79:500-7.
14. Garcin B, Houdart E, Porcher R, et al. Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology. 2012;78:626-31.
15. Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31:1307-10. (Pubitemid 30351250)
16. Osipov A, Koennecke HC, Hartmann A, et al. Seizures in cerebral arteriovenous malformations: type, clinical course, and medical management. Interventional Neuroradiology. 1997;3:37-41. (Pubitemid 27261270)
17. Ennoksson P, Bynke H. Visual field defects in arteriovenous aneurysma of the brain. Acta Ophtalmol. 1958;36:586.
18. Troost BT, Newton TH. Occipital lobe arteriovenous malformations: clinical and radiologic features in 26 cases with comments on differentiation from migraine. Arch Ophthalmol. 1975;93:250-6.
19. Englot DJ, Young WL, Han SJ, et al. Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients. Neurosurgery. 2012;71:572-80.
20. Mackenzie I. The clinical presentation of the cerebral angioma: a review of 50 cases. Brain. 1953;76:184-214.
21. Northfield DWC. Angiomatous malformations of the brain. Guys Hosp Rep. 1940;90:149.
22. Evans RW. Diagnostic testing for the evaluation of headaches. Neurologic Clin. 1996;14:1-26. (Pubitemid 26064179)
23. Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290-5. (Pubitemid 39664252)
24. Lazar RM, Connaire K, Marshall RS, et al. Developmental deficits in adult patients with arteriovenous malformations. Arch Neurol. 1999;56:103-6. (Pubitemid 29046916)
25. Hai J, Wan JF, Lin Q, et al. Cognitive dysfunction induced by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations. Brain Res. 2009;1301:80-8.
26. Hai J, Su SH, Lin Q, et al. Cognitive impairment and changes of neuronal plasticity in rats of chronic cerebral hypoperfusion associated with cerebral arteriovenous malformations. Acta Neurologica Belgica. 2010;110:180-5.
27. McKissock W, Paterson JH. A clinical survey of intracranial angiomas with special reference to their mode of progression and surgical treatment: a report of 110 cases. Brain. 1956;79:233-66.
28. McCormick WF, Nofzinger JD. «Cryptic» vascular malformations of the central nervous system. J Neurosurg. 1966;24:865-75.
29. Guidetti B, Delitala A. Intracranial arteriovenous malformations. Conservative and surgical treatment. J Neurosurg. 1980;53:149-52. (Pubitemid 10039963)
30. •• Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37:1243-7. The clinical outcomes are far more mild from bAVMs than from other forms of primary brain hemorrhage. (Pubitemid 43731870)
31. •• van Beijnum J, Lovelock CE, Cordonnier C, et al. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132:537-43. Population-based study.
32. • Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476-83. Widely-used grading system for predicting outcome from surgery: size, location and 'eloquence' are the major variables. (Pubitemid 16000693)
33. Du R, Dowd CF, Johnston SC. et al. Interobserver variability in grading of brain arteriovenous malformations using the Spetzler-Martin system. Neurosurgery. 2005;57:668-75; discussion 75.
34. Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council. American Stroke Association. Stroke. 2001;32:1458-71. (Pubitemid 32530442)
35. • Hartmann A, Mast H, Mohr JP, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005;36:2431-5. Outcomes vary by treatment modality. (Pubitemid 41566972)
36. • Lawton MT, Du R, Tran MN, et al. Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery. 2005;56:485-93; discussion -93. Outcomes worse for those who had not bled.
37. • Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352:146-53. Those not having bled prior to therapy have more frequent hemorrhage from radiotherapy. (Pubitemid 40096611)
38. Parkhutik V, Lago A, Tembl JI, et al. Postradiosurgery hemorrhage rates of arteriovenous malformations of the brain: influencing factors and evolution with time. Stroke. 2012;43:1247-52.
39. •• van Beijnum J, van der Worp HB, Buis DR. et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306:2011-9. Major review article justifying a clinical trial.
40. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73:387-91. (Pubitemid 20260008)
41. Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350:1065-8. (Pubitemid 27437857)
42. • Mohr JP, Moskowitz AJ, Parides M. et al. Hull down on the horizon: a Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) Trial. Stroke. 2012;43:1744-5. Rebuttal to the latest criticisms of the ARUBA trial.
43. Hernesniemi JA, Dashti R, Juvela S, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63:823-9; discussion 9-31.
44. Laakso A, Dashti R, Juvela S, et al. Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery. 2011;68:372-7; discussion-8.
45. Berman MF, Hartmann A, Mast H, et al. Determinants of resource utilization in the treatment of brain arteriovenous malformations. AJNR. 1999;20:2004-8.
46. Brown Jr RD. Unruptured brain AVMs: to treat or not to treat. Lancet Neurol. 2008;7:195-6.
47. Kim H, Pourmohamad T, McCulloch CE, et al. Multicenter study of predictors for intracranial haemorrhage risk in the natural history of brain arteriovenous malformations (bAVM). 1st World AVM Congress. Edinburgh; 2012.
48. •• Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66:1350-5. Lowest risk for those with no deep bAVM location or deep venous drainage. (Pubitemid 43739643)
49. Stapf C, Mohr JP, Choi JH, et al. Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol. 2006;19:63-8. (Pubitemid 43172707)
50. Stapf C, Mohr JP. Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke. 2007;38:3308-9. (Pubitemid 350175755)
51. Cockroft KM. Unruptured brain arteriovenous malformations should be treated conservatively: no. Stroke. 2007;38:3310-1.
52. Mohr JP, Moskowitz AJ, Stapf C, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41:e537-40.
53. Ross J, Al-Shahi Salman R. Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev. 2010:CD003436.
54. Frenzel T, Lee CZ, Kim H, et al. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008;25:157-63. (Pubitemid 351280391)
55. Fiehler J, Stapf C. ARUBA-beating natural history in unruptured brain AVMs by intervention. Neuroradiology. 2008;50:465-7.
56. Mathiesen T. Arguments against the proposed randomised trial (ARUBA). Neuroradiology. 2008;50:469-71.
57. Cockroft KM, Jayaraman MV, Amin-Hanjani S, et al. A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations' (ARUBA's) trial design challenges notions of external validity. Stroke. 2012;43:1979-81.
58. Raymond J, Naggara O, Guilbert F, Altman DG. Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformations. AJNR. 2011;32:809-12.
59. Houdart E. The need for new regulations on randomized clinical trials in surgical treatments. Neuroradiology. 2010;52:1061-2.
60. •• Kim H, McCulloch CE, Johnston SC. et al. Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol. 2010;171:1317-22. Calculations of risk for hemorrhage based on date of discovery vs, assumption of presence since birth.
61. Ovalle F, Shay SD, Mericle RA. Delayed intracerebral hemorrhage after uneventful embolization of brain arteriovenous malformations is related to volume of embolic agent administered: multivariate analysis of 13 predictive factors. Neurosurgery. 2012;70:313-20.
62. Mohr JP, Mast H, Kejda-Scharler J, et al. Proposal for an AVM Registry. 1st World AVM Congress. Edinburgh; 2012.
63. Lazar RM, Marshall RS, Pile-Spellman J, et al. Anterior translocation of language in patients with left cerebral arteriovenous malformation. Neurology. 1997;49:802-8. (Pubitemid 27428026)
64. Lepski G, Honegger J, Liebsch M, et al. Safe resection of arteriovenous malformations in eloquent motor areas aided by functional imaging and intraoperative monitoring. Neurosurgery. 2012;70:276-88; discussion 88-9.
65. Koga T, Maruyama K, Kamada K, et al. Outcomes of diffusion tensor tractography-integrated stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;82:799-802.
66. Ichikawa T, Suzuki K, Sasaki T, et al. Utility and the limit of motor evoked potential monitoring for preventing complications in surgery for cerebral arteriovenous malformation. Neurosurgery. 2010;67:ons222-8; discussion 8.
67. Kejda-Scharler J, DeLaPaz R, Mohr JP. Use of MRI, fMRI, and DTI for interventional decision after minimal AVM haemorrhage 1st World AVM Congress. Edinburgh; 2012.